394 related articles for article (PubMed ID: 12364356)
21. Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats.
Lee JH; Xia S; Ragolia L
Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R144-54. PubMed ID: 18463192
[TBL] [Abstract][Full Text] [Related]
22. AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats.
Barber MN; Sampey DB; Widdop RE
Hypertension; 1999 Nov; 34(5):1112-6. PubMed ID: 10567191
[TBL] [Abstract][Full Text] [Related]
23. High-salt diet inhibits expression of angiotensin type 2 receptor in resistance arteries.
Gonzalez M; Lobos L; Castillo F; Galleguillos L; Lopez NC; Michea L
Hypertension; 2005 May; 45(5):853-9. PubMed ID: 15809360
[TBL] [Abstract][Full Text] [Related]
24. Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats.
Cervenka L; Wang CT; Navar LG
Am J Physiol; 1998 May; 274(5):F940-5. PubMed ID: 9612332
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
Cox SL; Story DF; Ziogas J
Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
[TBL] [Abstract][Full Text] [Related]
26. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II receptor antagonist improves age-related endothelial dysfunction.
Kansui Y; Fujii K; Goto K; Abe I; Iida M
J Hypertens; 2002 Mar; 20(3):439-46. PubMed ID: 11875311
[TBL] [Abstract][Full Text] [Related]
28. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
[TBL] [Abstract][Full Text] [Related]
29. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE
Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804
[TBL] [Abstract][Full Text] [Related]
30. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
[TBL] [Abstract][Full Text] [Related]
31. AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat.
Jugdutt BI; Menon V
Mol Cell Biochem; 2004 Jul; 262(1-2):203-14. PubMed ID: 15532725
[TBL] [Abstract][Full Text] [Related]
32. Enhancement by exogenous and locally generated angiotensin II of purinergic neurotransmission via angiotensin type 1 receptor in the guinea-pig isolated mesenteric artery.
Onaka U; Fujii K; Abe I; Fujishima M
Br J Pharmacol; 1997 Nov; 122(5):942-8. PubMed ID: 9384513
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor.
Yatabe J; Yoneda M; Yatabe MS; Watanabe T; Felder RA; Jose PA; Sanada H
Endocrinology; 2011 Apr; 152(4):1582-8. PubMed ID: 21303953
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries.
Thorup C; Kornfeld M; Winaver JM; Goligorsky MS; Moore LC
Pflugers Arch; 1998 Feb; 435(3):432-4. PubMed ID: 9426302
[TBL] [Abstract][Full Text] [Related]
35. Luminal ANG II is internalized as a complex with AT
Ferrão FM; Cardoso LHD; Drummond HA; Li XC; Zhuo JL; Gomes DS; Lara LS; Vieyra A; Lowe J
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F440-F449. PubMed ID: 28468964
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease.
van de Wal RM; van der Harst P; Wagenaar LJ; Wassmann S; Morshuis WJ; Nickenig G; Buikema H; Plokker HW; van Veldhuisen DJ; van Gilst WH; Voors AA
J Cardiovasc Pharmacol; 2007 Oct; 50(4):372-9. PubMed ID: 18049304
[TBL] [Abstract][Full Text] [Related]
37. Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system.
Nguyen L; Ager EI; Neo J; Christophi C
J Gastroenterol Hepatol; 2016 Oct; 31(10):1773-1782. PubMed ID: 26849969
[TBL] [Abstract][Full Text] [Related]
38. Increased AT(2)R protein expression but not increased apoptosis during cardioprotection induced by AT(1)R blockade.
Moudgil R; Musat-Marcu S; Xu Y; Kumar D; Jugdutt BI
Can J Cardiol; 2002 Oct; 18(10):1107-16. PubMed ID: 12420045
[TBL] [Abstract][Full Text] [Related]
39. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
Banday AA; Lokhandwala MF
Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
[TBL] [Abstract][Full Text] [Related]
40. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]